Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 67,581 | 201,644 | 191,736 | 175,331 | 79,448 |
| Depreciation Amortization | 20,065 | 94,654 | 71,078 | 46,990 | 22,443 |
| Income taxes - deferred | -5,397 | -18,337 | -21,653 | -19,544 | -8,255 |
| Accounts receivable | -28,935 | 47,779 | 43,546 | -37,769 | -45,153 |
| Other Working Capital | -101,888 | -47,084 | -47,287 | -96,418 | -63,984 |
| Other Operating Activity | 56,983 | 88,425 | 44,646 | 92,347 | 71,896 |
| Operating Cash Flow | $8,409 | $367,081 | $282,066 | $160,937 | $56,395 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,732 | -117,991 | 70,368 | 66,627 | N/A |
| PPE Investments | -6,099 | -30,339 | -22,154 | -14,741 | -7,217 |
| Net Acquisitions | N/A | 25,703 | 25,703 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -72,790 |
| Sale Of Investment | N/A | 176,833 | N/A | N/A | 108,307 |
| Investing Cash Flow | $633 | $54,206 | $73,917 | $51,886 | $28,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,301 | 47,781 | 37,231 | 21,394 | 10,954 |
| Common Stock Repurchased | -80,002 | -149,276 | -124,276 | -99,276 | -49,412 |
| Dividend Paid | -28,552 | -103,407 | -77,584 | -51,741 | -25,869 |
| Other Financing Activity | -34,887 | -31,910 | -29,385 | -27,566 | -25,766 |
| Financing Cash Flow | $-125,140 | $-236,812 | $-194,014 | $-157,189 | $-90,093 |
| Exchange Rate Effect | 6,790 | 5,120 | 8,819 | 9,415 | 8,504 |
| Beginning Cash Position | 817,966 | 628,371 | 628,371 | 628,371 | 628,371 |
| End Cash Position | 708,658 | 817,966 | 799,159 | 693,420 | 631,477 |
| Net Cash Flow | $-109,308 | $189,595 | $170,788 | $65,049 | $3,106 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,409 | 367,081 | 282,066 | 160,937 | 56,395 |
| Capital Expenditure | -6,099 | -30,339 | -22,154 | -14,741 | -7,217 |
| Free Cash Flow | 2,310 | 336,742 | 259,912 | 146,196 | 49,178 |